Short-Acting Endovenous Beta-Blockers and Echocardiography-Guided Heart Rate Optimization in A Type 4a Myocardial Infarction Complicated by Cardiogenic Shock

Background Landiolol, a short-acting, highly-?1-selective beta-blocker with- out negative inotropic effect, could offer the opportunity to mod- ulate heart rate and/or rhythm in different critical settings. Echo- cardiographic estimate of hemodynamic parameters is a useful way to monitor critically ill patients and evaluate the effects of the ongoing therapy.

• Fulltext Article